Literature DB >> 7883778

Growth stimulation of ferritin of human leukemia cells in vitro.

N Kikyo1, K Hagiwara, Y Yazaki, T Okabe.   

Abstract

Ferritin has been reported to inhibit the growth of some leukemia cells in serum-supplemented culture. Recently we have found that ferritin stimulates the proliferation of human acute myeloblastic leukemia cells HL-60 and erythroleukemia cells K-562-T1 in serum-free medium. In this study, we examined the effect of ferritin against 14 human leukemia cell lines using human heart ferritin in serum-depleted culture medium. Among 14 cell lines tested, 10 were stimulated to proliferate by ferritin (maximum response at 30-300 ng/ml) with 0-1% fetal calf serum (FCS). The growth of all the cell lines was significantly inhibited by ferritin in the presence of 10% FCS. These results suggest that ferritin has dual functions; it promotes the growth of leukemia cells with low concentrations of FCS, but suppresses their growth with high concentrations of FCS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883778     DOI: 10.1007/bf01202216

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  Characterization of the binding of ferritin to the rat liver ferritin receptor.

Authors:  U Mack; E L Storey; L W Powell; J W Halliday
Journal:  Biochim Biophys Acta       Date:  1985-12-13

2.  Characteristics of a ferritin-binding protein present in human serum.

Authors:  V Bellotti; P Arosio; M Cazzola; A Cozzi; S Levi; F Meloni; E Zoppone
Journal:  Br J Haematol       Date:  1987-04       Impact factor: 6.998

3.  Interaction between rabbit erythroblast ferritin and normal plasma proteins.

Authors:  H Yamada; T G Gabuzda
Journal:  Blood       Date:  1974-06       Impact factor: 22.113

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The effect of isoferritins on granulopoiesis.

Authors:  G Sala; M Worwood; A Jacobs
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

6.  Purification and characterization of a cell growth factor from a human leukemia cell line: immunological identity with ferritin.

Authors:  N Kikyo; M Suda; N Kikyo; K Hagiwara; K Yasukawa; M Fujisawa; Y Yazaki; T Okabe
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

7.  Use of a monoclonal antibody against human heart ferritin for evaluating acidic ferritin concentration in human serum.

Authors:  M Cazzola; P Arosio; V Bellotti; G Bergamaschi; L Dezza; C Iacobello; G Ruggeri
Journal:  Br J Haematol       Date:  1985-11       Impact factor: 6.998

8.  Diagnostic value of serum ferritin in primary hepatocellular carcinoma.

Authors:  E Giannoulis; C Arvanitakis; A Nikopoulos; I Doutsos; A Tourkantonis
Journal:  Digestion       Date:  1984       Impact factor: 3.216

9.  Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.

Authors:  S Chiba; F Takaku; T Tange; K Shibuya; C Misawa; K Sasaki; K Miyagawa; Y Yazaki; H Hirai
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

10.  Serum ferritin concentration in early breast cancer.

Authors:  A Jacobs; B Jones; C Ricketts; R D Bulbrook; D Y Wang
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

View more
  2 in total

1.  Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.

Authors:  Simon Swingler; Jin Zhou; Catherine Swingler; Ann Dauphin; Thomas Greenough; Paul Jolicoeur; Mario Stevenson
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

2.  Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia.

Authors:  Hyunsung Park; Haerim Chung; Jungyeon Lee; Jieun Jang; Yundeok Kim; Soo Jeong Kim; Jin Seok Kim; Yoo Hong Min; June Won Cheong
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.